Psittacosis Parrot Fever

Psittacosis, commonly known as parrot fever, is an infectious disease caused by the obligate intracellular bacterium Chlamydia psittaci. The disease affects a wide range of bird species and holds particular significance in avian medicine because it is zoonotic, meaning it can be transmitted from birds to humans. Although the name parrot fever reflects the historical association with psittacine birds such as parrots, cockatoos, and budgerigars, the organism infects over 460 avian species spanning virtually every taxonomic order, including pigeons, poultry, raptors, shorebirds, and passerines. When the disease occurs in non-psittacine birds, it is sometimes referred to as ornithosis, though the causative organism is the same.

The history of psittacosis as a recognized disease dates to the late nineteenth century, but the infection gained widespread public attention during a pandemic event in 1929 and 1930 that spread across multiple continents through the international trade of imported parrots. That outbreak resulted in significant human illness and mortality and prompted regulatory responses including import restrictions on psittacine birds in several countries. While improved diagnostics, treatment options, and husbandry practices have substantially reduced the incidence and severity of psittacosis in both birds and humans since that era, the disease remains a relevant concern for bird owners, avian veterinarians, breeders, and public health authorities.

Chlamydia psittaci is a resilient organism that can persist in dried fecal material, feather dust, and respiratory secretions for extended periods under favorable environmental conditions. This environmental persistence contributes to the challenge of disease control, as birds can become infected through inhalation of contaminated particles without direct contact with an actively ill bird. Infected birds may shed the organism intermittently, sometimes appearing clinically healthy while serving as a source of environmental contamination and potential transmission to other birds and humans in the household.

For bird owners, psittacosis occupies a unique position among avian diseases because its zoonotic potential creates health implications that extend beyond the bird itself. A diagnosis of psittacosis in a pet bird triggers public health reporting requirements in many jurisdictions and necessitates concurrent evaluation of human household members who may have been exposed. Understanding the disease, its transmission pathways, clinical presentation, and treatment is essential not only for the welfare of the bird but for the safety of everyone in the home.

This article provides a thorough examination of psittacosis, covering the biology of the causative organism, how it spreads between birds and to humans, the clinical signs it produces in different species, diagnostic approaches and treatment protocols, prevention strategies, and the public health framework surrounding the disease. Equipped with this knowledge, bird owners and those considering bird ownership can make informed decisions about risk management and respond appropriately if psittacosis is suspected.

Chlamydia psittaci is a gram-negative, obligate intracellular bacterium belonging to the family Chlamydiaceae. Unlike many bacteria that can replicate independently in the environment, C. psittaci requires a host cell to complete its reproductive cycle, alternating between two distinct morphological forms. The elementary body is the environmentally stable, metabolically inert form that functions as the infectious particle, capable of surviving outside a host for weeks to months under dry, cool conditions. Upon entering a susceptible host cell, the elementary body transforms into the reticulate body, the metabolically active replicative form that divides within a membrane-bound inclusion inside the host cell. After multiple rounds of division, the reticulate bodies convert back to elementary bodies, which are released when the cell ruptures, ready to infect new cells or contaminate the environment.

Transmission between birds occurs primarily through inhalation of aerosolized particles from dried feces, feather dust, and respiratory secretions containing elementary bodies. The respiratory route is the most efficient pathway for infection, as the organism readily colonizes the epithelial cells lining the respiratory tract. Direct contact with infected nasal or ocular discharge can also transmit the bacterium. Fecal-oral transmission occurs when birds ingest contaminated food or water, and parent birds can transmit the organism to nestlings through crop feeding. Vertical transmission from hen to egg has been documented but appears to be relatively uncommon compared to horizontal respiratory spread.

The organism is classified into multiple genotypes, designated by letters, with different genotypes showing varying degrees of host specificity and virulence. Genotype A is predominantly associated with psittacine birds and is considered the most virulent strain for human infection. Genotype B is commonly found in pigeons and doves. Genotypes C and D are associated with poultry and waterfowl respectively. Genotype E, sometimes called the Cal-10 strain, has been isolated from a broad range of host species including both birds and mammals. Understanding genotype distribution has epidemiological significance because it helps trace transmission pathways and assess zoonotic risk, as some genotypes pose greater risk to humans than others.

Environmental persistence of C. psittaci elementary bodies is a critical factor in disease transmission and control. The organism can remain viable in dried fecal material for months under cool, shaded conditions, making contaminated cage surfaces, air filters, ventilation systems, and accumulated debris potential reservoirs of infection. In bird-keeping environments where multiple birds are housed, particularly breeding facilities, pet stores, and bird shows, the concentration of infectious particles in the air can reach levels sufficient to infect birds and humans even without close direct contact with an obviously ill individual. This environmental resilience underscores the importance of rigorous hygiene practices in any setting where birds are kept.

Stress plays a significant role in the epidemiology of psittacosis by triggering shedding of the organism in latently infected birds. Birds that carry C. psittaci without showing clinical signs may begin shedding large quantities of elementary bodies in their droppings and respiratory secretions when subjected to stressors such as transport, rehoming, overcrowding, breeding activity, concurrent illness, nutritional deficiency, or environmental disruption. This stress-induced shedding explains why outbreaks commonly occur in the period following bird acquisition, during breeding seasons, and in association with other destabilizing events. It also means that a bird tested negative for psittacosis at one point may later become a shedder under changed circumstances, complicating efforts to certify birds as definitively free of infection.

The clinical presentation of psittacosis in birds ranges from acute severe illness with high mortality to chronic subclinical infection with no outward signs of disease. The severity of clinical manifestation depends on the virulence of the infecting C. psittaci strain, the bird species involved, the immune status and age of the individual, concurrent stressors, and the dose of organism to which the bird was exposed. Young birds, immunocompromised individuals, and those under significant stress tend to develop more severe disease, while healthy adult birds with robust immune systems may harbor the organism asymptomatically for extended periods.

Respiratory signs are among the most common clinical manifestations and may include nasal discharge ranging from serous to mucopurulent, sneezing, dyspnea, and conjunctivitis with periorbital swelling. Affected birds may show audible respiratory sounds, tail bobbing during breathing, and open-mouth breathing in advanced cases. The respiratory signs reflect the organism's tropism for respiratory epithelium and the inflammatory response it provokes in the airways, air sacs, and lungs. Air sacculitis, visible on radiographic examination as thickened and opacified air sacs, is a characteristic finding in birds with respiratory psittacosis.

Gastrointestinal signs frequently accompany or occasionally dominate the clinical picture. Affected birds may produce abnormal droppings characterized by lime-green or yellow-green urates, loose or watery fecal components, and sometimes frank blood. The distinctive bright green coloration of urates in psittacosis results from biliverdinuria secondary to hepatic inflammation, as the liver is a primary target organ for C. psittaci infection. Decreased appetite, weight loss, and regurgitation may also occur. Hepatomegaly and splenomegaly, detectable on physical examination or radiographic imaging, reflect the systemic nature of the infection and its particular affinity for reticuloendothelial organs.

Non-specific systemic signs often accompany the organ-specific manifestations and may include lethargy, fluffed feathers, decreased vocalization, reduced interest in social interaction, and a generally depressed demeanor. Feather quality may deteriorate in chronically infected birds due to the metabolic burden of persistent infection and associated nutritional compromise. Some birds develop polyuria and polydipsia secondary to renal involvement. Neurological signs, though less common, can occur when the organism crosses the blood-brain barrier and may manifest as tremors, ataxia, head tilt, or seizures.

The subclinical carrier state represents a significant epidemiological challenge. Birds carrying C. psittaci without showing clinical signs appear entirely healthy on routine observation and may pass casual veterinary examination without arousing suspicion. These carriers shed the organism intermittently, particularly during periods of physiological stress, creating an unpredictable source of environmental contamination and potential transmission. The carrier state can persist for months or years, and some birds may cycle between periods of clinical disease and apparent health. This carrier dynamic is a primary reason that newly acquired birds should be evaluated for psittacosis regardless of their outward appearance, and why quarantine protocols are strongly recommended before introducing new birds into an existing collection.

The zoonotic dimension of psittacosis is what elevates it from a significant avian disease to a public health concern requiring coordinated medical and veterinary response. Humans contract psittacosis primarily through inhalation of aerosolized C. psittaci elementary bodies from dried bird droppings, feather dust, respiratory secretions, or contaminated cage debris. Direct contact with an infected bird through handling, beak-to-mouth contact, or bites can also transmit the organism, though respiratory inhalation of contaminated particles is the far more common route. Person-to-person transmission is rare but has been documented in a small number of cases, generally involving close contact with a severely ill individual.

Human psittacosis typically presents as a systemic febrile illness that can range from mild flu-like symptoms to severe atypical pneumonia requiring hospitalization. The incubation period in humans is generally five to fourteen days following exposure. Common symptoms include fever, chills, headache often described as severe, nonproductive cough, myalgia, and malaise. Physical examination may reveal hepatosplenomegaly and auscultatory findings consistent with pneumonia. Chest radiography frequently shows patchy infiltrates or consolidation that may not correlate with the relatively modest auscultatory findings, a pattern sometimes described as radiographic-clinical dissociation.

Certain populations face elevated risk for severe human psittacosis. Individuals with compromised immune systems, pregnant women, elderly persons, and those with pre-existing pulmonary disease may develop more severe manifestations including respiratory failure, endocarditis, myocarditis, encephalitis, and multi-organ dysfunction. Occupational exposure increases risk for pet store workers, avian veterinarians and veterinary technicians, poultry processing workers, bird breeders, and wildlife rehabilitators who regularly handle birds or work in environments with high concentrations of avian fecal dust. These at-risk groups benefit from heightened awareness and appropriate protective practices.

Diagnosis of human psittacosis requires clinical suspicion guided by a history of bird exposure, as the disease is frequently misdiagnosed as community-acquired pneumonia of other etiology when the avian exposure history is not elicited or not volunteered by the patient. Laboratory confirmation in humans relies on serological testing, typically microimmunofluorescence assay demonstrating a fourfold rise in antibody titer between acute and convalescent sera, or PCR-based detection of C. psittaci DNA in respiratory specimens. Treatment in humans follows the same antibiotic principles as in birds, with tetracycline-class antibiotics, particularly doxycycline, serving as the first-line agents. Early appropriate antibiotic therapy dramatically improves outcomes, while delayed treatment increases the risk of complications.

Psittacosis is a nationally notifiable disease in many countries including the United States, where confirmed and probable cases must be reported to public health authorities. When psittacosis is diagnosed in a pet bird, the attending veterinarian is typically obligated to report the case to state or local animal health officials, who may coordinate with human public health departments to evaluate exposed household members and ensure appropriate follow-up. This reporting framework exists because individual cases may signal broader exposures affecting multiple people, particularly in commercial bird-keeping operations, and because accurate surveillance data are essential for understanding and managing the epidemiology of this zoonotic infection.

Diagnosing psittacosis in birds presents considerable challenges because no single test provides definitive results under all circumstances, and the clinical signs overlap extensively with other common avian diseases. A comprehensive diagnostic approach combining clinical assessment, imaging, serology, and molecular testing provides the most reliable basis for diagnosis. Avian veterinarians generally recommend testing for psittacosis in any bird presenting with respiratory signs, hepatosplenomegaly, or characteristic changes in droppings, as well as in asymptomatic newly acquired birds and those with known exposure to confirmed cases.

Polymerase chain reaction testing represents the most widely used and specific diagnostic method currently available for detecting C. psittaci in birds. PCR assays detect the organism's DNA in samples collected from the choana, conjunctiva, cloaca, or feces. Choanal and cloacal swabs collected simultaneously increase sensitivity because shedding may occur from the respiratory tract, the gastrointestinal tract, or both depending on the stage of infection. The primary limitation of PCR testing is that it detects the organism only when it is being actively shed, meaning that intermittent shedders may test negative during quiescent periods. Serial testing over multiple sampling points improves the likelihood of detecting intermittent shedders.

Serological testing measures the antibody response to C. psittaci infection and provides different diagnostic information than PCR. Elementary body agglutination and immunofluorescence assays detect circulating antibodies, with elevated titers suggesting active or recent infection. However, serological results require careful interpretation because antibodies may persist for extended periods following resolved infection, newly infected birds may not yet have developed a measurable antibody response, and cross-reactivity with other chlamydial species can produce false-positive results. A fourfold change in titer between paired sera collected two to four weeks apart provides stronger evidence of active infection than a single elevated titer.

Hematologic and biochemical findings, while not specific for psittacosis, support the clinical suspicion and help assess disease severity. Leukocytosis with heterophilia and monocytosis is commonly observed in actively infected birds. Elevated liver enzymes, particularly aspartate aminotransferase and lactate dehydrogenase, reflect the hepatic involvement characteristic of systemic C. psittaci infection. Elevated bile acids further support hepatic dysfunction. Radiographic imaging may reveal hepatomegaly, splenomegaly, air sac thickening, and pulmonary infiltrates that collectively paint a picture consistent with psittacosis, particularly when combined with supporting laboratory findings.

Post-mortem examination and histopathology provide the most definitive diagnosis but are obviously available only for birds that have died or been euthanized. Gross necropsy findings typically include enlarged, discolored liver and spleen, air sac thickening with fibrinous exudate, and pericarditis. Histopathologic examination reveals characteristic intracytoplasmic inclusions within macrophages and hepatocytes, confirming the presence of the organism within tissues. Immunohistochemistry and PCR performed on fixed tissue samples can confirm the identity of the organism. These post-mortem findings are valuable for confirming diagnosis in deceased birds and for guiding management decisions regarding other birds in the same collection that may have been exposed.

Treatment of psittacosis in birds centers on prolonged antibiotic therapy targeting C. psittaci, combined with supportive care measures appropriate to the severity of clinical disease. Tetracycline-class antibiotics are the established first-line treatment, with doxycycline being the preferred agent due to its superior pharmacokinetics, broader tissue distribution, and more convenient dosing characteristics compared to older tetracyclines like chlortetracycline. The treatment duration is a critical aspect of psittacosis management: current guidelines recommend a minimum of 45 days of continuous doxycycline therapy to achieve reliable elimination of the organism, as shorter courses risk incomplete clearance and relapse.

Doxycycline can be administered through several routes depending on the clinical situation, species, and practical considerations. Oral administration, either directly by syringe or compounded into a palatable suspension, provides reliable dosing for individual pet birds whose owners can manage daily medication. Intramuscular injection of long-acting doxycycline formulations, typically doxycycline hyclate in a poloxamer gel vehicle, allows for weekly or biweekly dosing that circumvents the challenges of daily oral administration but requires repeated veterinary visits or owner training in injection technique. Medicated water and medicated feed formulations using chlortetracycline are sometimes used for flock treatment situations where individual dosing is impractical, though achieving consistent therapeutic drug levels through these routes is less reliable.

Dietary management during treatment requires attention because calcium-rich foods interfere with tetracycline absorption through chelation. Birds receiving oral doxycycline should have their access to calcium-rich foods restricted during the treatment period, which may involve temporarily removing cuttlebone, mineral blocks, and high-calcium vegetables from the diet. Pelleted diets with high calcium content may also reduce drug efficacy. The treating veterinarian should provide specific dietary guidance that balances the need for adequate nutrition during illness recovery against the requirement for optimal antibiotic absorption.

Supportive care plays an essential role in managing clinical psittacosis, particularly in birds presenting with moderate to severe disease. Fluid therapy addresses dehydration resulting from reduced water intake and increased insensible losses during illness. Nutritional support through assisted feeding may be necessary for anorexic birds or those with gastrointestinal involvement preventing adequate voluntary intake. Environmental temperature management, typically maintaining the bird in a warm, quiet environment at the higher end of its thermoneutral zone, reduces metabolic demand during recovery. Nebulization therapy may benefit birds with significant respiratory involvement by helping to clear airway secretions and deliver supplemental humidity to inflamed respiratory tissues.

Monitoring during and after treatment is essential for confirming therapeutic success. Follow-up PCR testing should be performed after completion of the full antibiotic course to verify clearance of the organism. Testing too early during treatment may yield false reassurance, as the antibiotic suppresses bacterial replication without necessarily eliminating all intracellular organisms until sufficient treatment duration has elapsed. Some veterinarians recommend repeat testing at two to four weeks after treatment completion to confirm sustained clearance. Birds that remain PCR-positive after a complete treatment course may require extended therapy or evaluation for treatment-resistant infection. All birds in the household or collection should be evaluated and potentially treated concurrently, as untreated asymptomatic carriers can reinfect treated birds after therapy concludes.

Preventing psittacosis requires a multi-layered approach combining quarantine protocols, hygiene practices, environmental management, and informed acquisition decisions. The cornerstone of prevention for any bird owner is the quarantine and testing of newly acquired birds before they are introduced to an existing flock or household. A quarantine period of 30 to 45 days in a separate airspace from resident birds, combined with diagnostic testing for C. psittaci during this period, provides a reasonable opportunity to identify infected individuals before they can expose other birds in the home. Testing during quarantine should include PCR sampling from both choanal and cloacal sites, ideally repeated at least once during the quarantine period to account for intermittent shedding.

Environmental hygiene is the most practically impactful prevention measure available to bird owners on a daily basis. Regular, thorough cleaning of cages, perches, food and water dishes, and surrounding areas reduces the accumulation of dried fecal material that serves as the primary environmental reservoir of C. psittaci elementary bodies. Cage papers or substrates should be changed daily, and hard surfaces should be cleaned with effective disinfectants. Quaternary ammonium compounds, household bleach diluted to appropriate concentration, and chlorine dioxide-based products are effective against C. psittaci on environmental surfaces. Allowing cage components to dry completely after disinfection is important because the elementary bodies are more susceptible to inactivation in dry conditions after their protective matrix of fecal material has been removed.

Airborne transmission control addresses the respiratory route that is the primary pathway for both bird-to-bird and bird-to-human infection. Wetting down cage substrates and surfaces before disturbing them reduces the aerosolization of dried fecal particles during cleaning. Adequate ventilation in bird-keeping areas dilutes airborne concentrations of potentially infectious particles. HEPA air filtration systems can capture particles in the size range relevant to C. psittaci transmission. Avoid using high-pressure spraying or dry sweeping methods to clean bird areas, as these practices generate aerosols that dramatically increase airborne particle concentrations and exposure risk for both birds and humans in the space.

Source-level prevention involves making informed decisions about where and from whom birds are acquired. Reputable breeders who maintain closed or carefully managed flocks, practice routine testing, enforce quarantine protocols for new additions, and provide health documentation for birds leaving their facility represent lower-risk sources compared to high-turnover environments like bird fairs, swap meets, or facilities with poor hygiene standards. Requesting documentation of recent psittacosis testing for any bird being considered for purchase provides a baseline, though a single negative test does not guarantee freedom from latent infection. Establishing a relationship with an avian veterinarian and scheduling a new-bird examination promptly after acquisition creates a professional checkpoint for evaluating health status.

Personal protective measures are advisable for individuals who are at elevated risk for severe human psittacosis or who work regularly with birds of unknown health status. Wearing a properly fitted N95 respirator or equivalent during cage cleaning and when handling unfamiliar birds reduces inhalation exposure. Thorough handwashing after handling birds, cleaning cages, or touching bird-related items prevents fecal-oral and mucous membrane transmission routes. Immunocompromised individuals, pregnant women, and those with chronic respiratory conditions should discuss the risks of bird ownership with their healthcare provider, as the zoonotic risk may influence decisions about bird keeping or the level of protective measures adopted in the household.

Psittacosis occupies a distinctive position among avian diseases because its zoonotic nature places it at the intersection of veterinary medicine and public health, creating regulatory and reporting obligations that do not apply to most other bird diseases. In the United States, psittacosis is classified as a nationally notifiable disease by the Centers for Disease Control and Prevention, and most states require that confirmed or suspected cases in both humans and birds be reported to the appropriate health authorities. The specifics of reporting requirements, including which agency receives the report, the timeline for reporting, and the criteria that trigger a report, vary by jurisdiction, making it important for bird owners and veterinarians to be familiar with local regulations.

The Compendium of Measures to Control Chlamydia psittaci Infection Among Humans and Pet Birds, jointly published by the National Association of State Public Health Veterinarians and periodically updated, serves as the primary guidance document for psittacosis control in the United States. This compendium outlines recommendations for diagnosis, treatment, quarantine, and environmental decontamination applicable to pet birds, avian breeding operations, pet stores, and other settings where birds are maintained. While the compendium itself is advisory rather than legally binding, many state and local regulations incorporate its recommendations by reference, giving them practical regulatory force in those jurisdictions.

Import regulations represent another layer of the regulatory framework affecting psittacosis control. International trade in psittacine birds is subject to health certification requirements designed to prevent the introduction of infectious diseases including psittacosis into importing countries. In the United States, imported psittacine birds must undergo quarantine at USDA-approved facilities and receive prophylactic treatment with chlortetracycline-medicated feed for a minimum of 30 days. These import quarantine requirements exist alongside CITES regulations governing trade in protected species, creating a dual regulatory framework that addresses both conservation and disease control objectives.

When psittacosis is diagnosed in a pet bird, the resulting regulatory response typically involves coordination between veterinary and human health authorities. The attending veterinarian reports the avian case to the state veterinarian or equivalent animal health authority. Concurrently, if human illness is identified, the treating physician reports to the state health department. Public health investigators may contact the bird owner to identify all potentially exposed individuals, recommend medical evaluation for those with compatible symptoms, assess the scope of potential exposure, and ensure that appropriate treatment and environmental decontamination measures are implemented. This coordinated response reflects the One Health perspective that recognizes the interconnection of animal health, human health, and environmental factors in managing zoonotic diseases.

Bird owners should approach reporting requirements as a protective mechanism rather than a punitive one. The reporting system exists to ensure that exposed individuals receive timely medical evaluation and treatment, that the source of infection is identified and managed to prevent further transmission, and that surveillance data accurately reflect the epidemiology of the disease within the community. Veterinarians can guide owners through the reporting process and explain what to expect from public health follow-up. Understanding these regulatory dimensions before a potential diagnosis removes uncertainty from an already stressful situation and enables owners to cooperate effectively with the systems designed to protect both animal and human health.